De Wals Philippe, Van Allen Margot I, Lowry R Brian, Evans Jane A, Van den Hof Michiel C, Crowley Marian, Tairou Fassiatou, Uh Soo-Hong, Sibbald Barbara, Zimmer Pamela, Fernandez Bridget, Lee Nora S, Niyonsenga Théophile
Department of Social and Preventive Medicine, Laval University, Quebec City, Qc, Canada.
Birth Defects Res A Clin Mol Teratol. 2008 Feb;82(2):106-9. doi: 10.1002/bdra.20418.
Recent studies reported no reduction in the frequency of lipomeningomyelocele (LMMC) in Hawaii and Nova Scotia after the implementation of a folic acid food fortification policy in 1998, while a marked reduction in the prevalence of other NTDs was observed. This study was performed to assess the prevalence of LMMC in Canada in relation to the timing of food fortification.
The study population included livebirths, stillbirths, and terminations of pregnancies because of fetal anomaly to women residing in seven Canadian provinces, from 1993 to 2002. In each province, the ascertainment of NTD cases relied on multiple sources, and in addition all medical charts were reviewed. The study period was divided into pre-, partial, and full fortification periods, based on results of red cell folate tests published in the literature.
A total of 86 LMMC cases were recorded among approximately 1.9 million live births. The average birth prevalence rate was 0.05/1,000, ranging from a minimum of 0.01/1,000 in 2002 to a maximum of 0.08/1,000 in 1999. There was statistical heterogeneity between years (p = .01), but no pattern compatible with a decrease following fortification. Comparing the full fortification period with the prefortification period, there was a slight but not statistically significant decrease in LMMC birth prevalence.
LMMC seems to be pathogenically distinct from myelomeningocele and more studies are needed to understand the embryologic mechanisms leading to this condition, and the environmental and genetic factors involved in its etiology.
近期研究报告称,1998年实施叶酸食品强化政策后,夏威夷和新斯科舍的脂肪脊髓脊膜膨出(LMMC)发病率并未降低,而其他神经管缺陷(NTD)的患病率则显著下降。本研究旨在评估加拿大LMMC的患病率与食品强化时间的关系。
研究人群包括1993年至2002年居住在加拿大七个省份的活产儿、死产儿以及因胎儿异常而终止妊娠的妇女。在每个省份,NTD病例的确定依赖于多种来源,此外还对所有病历进行了审查。根据文献中发表的红细胞叶酸检测结果,将研究期分为强化前、部分强化和完全强化期。
在约190万例活产儿中,共记录了86例LMMC病例。平均出生患病率为0.05/1000,最低为2002年的0.01/1000,最高为1999年的0.08/1000。各年份之间存在统计学异质性(p = 0.01),但没有与强化后下降相符的模式。将完全强化期与强化前期进行比较,LMMC出生患病率略有下降,但无统计学意义。
LMMC在发病机制上似乎与脊髓脊膜膨出不同,需要更多研究来了解导致这种情况的胚胎学机制以及其病因中涉及的环境和遗传因素。